GlassScriptPhysician profile
Kylie E Ameres
NPI 1831954536
$1,061.94
in general payments reported to CMS, 2019-2025
14 companies · $644 in 2025
The $644 reported for 2025 was more than what 76% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $417 · 2025: $644.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $752 · Travel and Lodging: $211 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $751.96 |
| Travel and Lodging | $210.98 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $227.97 | 2025 | |
| Mayne Pharma Commercial LLC | $206.29 | 2024 | |
| Amgen INC. | $178.35 | 2024-2025 | Evenity, Prolia |
| Astellas Pharma US INC | $125.50 | 2024-2025 | Veozah |
| Hologic Sales and Service, LLC | $71.96 | 2024-2025 | Thinprep 2000 Processor, Aptima |
| Abbvie INC. | $41.57 | 2025 | |
| Medtronic, INC. | $41.21 | 2025 | Truclear |
| Sumitomo Pharma America, INC. | $35.17 | 2024-2025 | Myfembree |
| Merck Sharp & Dohme LLC | $32.95 | 2024 | Keytruda |
| Millicent US INC | $24.70 | 2024 | Intrarosa |
| Organon LLC | $24.59 | 2025 | Nexplanon |
| Exact Sciences Corporation | $17.46 | 2024 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $17.44 | 2025 | |
| Coopersurgical, INC. | $16.78 | 2025 | Paragard T 380a |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kylie Ameres listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.